Hostname: page-component-5c6d5d7d68-7tdvq Total loading time: 0 Render date: 2024-08-11T01:31:17.109Z Has data issue: false hasContentIssue false
  • English
  • Français

Attitudes of UK psychiatrists to the diagnosis of MCI in clinical practice

Published online by Cambridge University Press:  03 October 2012

Joanne Rodda ,
Santhosh Dontham Gandhi ,
Naaheed Mukadam  and
Zuzana Walker
Joanne Rodda*
Affiliation:
University College London, London, UK North East London NHS Foundation Trust, London, UK
Santhosh Dontham Gandhi
Affiliation:
North Essex Partnership NHS Foundation Trust, Chelmsford, UK
Naaheed Mukadam
Affiliation:
University College London, London, UK Camden and Islington NHS Foundation Trust, London, UK
Zuzana Walker
Affiliation:
University College London, London, UK North Essex Partnership NHS Foundation Trust, Chelmsford, UK
*
Correspondence should be addressed to: Joanne Rodda, Havering Older People's Services, 135-147 Church Road, Romford RM3 0SH, UK. Phone: +0844-6001282; Fax: +0844 4930230. Email: joanne.rodda@nelft.nhs.uk.
Get access Rights & Permissions [Opens in a new window]

Abstract

Background: Mild cognitive impairment (MCI) may represent a transitional stage between normal functioning and dementia. Following the initial criteria developed by Petersen et al. in 1999, which focused on memory deficit in the context of otherwise normal cognition and general functioning, the concept has evolved with the introduction of subtypes of MCI and improved understanding of etiology. Our aim was to investigate current practice as well as familiarity with and attitudes toward the concept of MCI amongst UK old age psychiatrists.

Method: We sent an anonymized postal survey to all clinicians on the Royal College of Psychiatrists Old Age Psychiatry register. Questions covered attitudes toward the concept of MCI in addition to diagnostic criteria and assessment tools used.

Results: The response rate was 39% (453 of 1,154 questionnaires returned completed). The majority of respondents were consultants (83%) and 91% diagnosed MCI. Only 4.4% of the respondents thought that the concept of MCI was not useful and 79% of them required a memory complaint from either the patient or an informant for a diagnosis, but the majority did not have a specific cut-off on cognitive testing. Eighty-two percent reported that they required no or minimal impairment in activities of daily living for a diagnosis of MCI. The two most frequently used tools for assessment were the Mini-Mental State Examination and the Addenbrooke's Cognitive Examination–Revised.

Conclusions: Our survey shows that in the United Kingdom, the term MCI has become part of everyday clinical practice in psychiatry, suggesting that clinicians find it a useful term to conceptualize the transitional stage between normal aging and dementia. However, there is variability in diagnostic practice.

Keywords

mild cognitive impairmentmemory clinicAlzheimer's diseasedementia
Type
Research Article
Information
International Psychogeriatrics , Volume 25 , Issue 2 , February 2013 , pp. 286 - 291
Copyright
Copyright © International Psychogeriatric Association 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Albert, M. S.et al. (2011). The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging–Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers and Dementia, 7, 270–279.CrossRefGoogle ScholarPubMed
Bennett, D. A.et al. (2002). Natural history of mild cognitive impairment in older persons. Neurology, 59, 198–205.CrossRefGoogle ScholarPubMed
Department of Health (2009). Living Well with Dementia: A National Dementia Strategy. London, UK: Department of Health.Google Scholar
Dubois, B.et al. (2010). Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurology, 9, 1118–1127.CrossRefGoogle ScholarPubMed
Frisoni, G. B., Fox, N. C., Jack, C. R. Jr., Scheltens, P. and Thompson, P. M. (2010). The clinical use of structural MRI in Alzheimer disease. Nature Reviews Neurology, 6, 67–77.CrossRefGoogle ScholarPubMed
Geslani, D. M., Tierney, M. C., Herrmann, N. and Szalai, J. P. (2005). Mild cognitive impairment: an operational definition and its conversion rate to Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 19, 383–389.CrossRefGoogle ScholarPubMed
Kalbe, E.et al. (2004). DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. International Journal of Geriatric Psychiatry, 19, 136–143.CrossRefGoogle ScholarPubMed
Lopez, O. L.et al. (2003). Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Archives of Neurology, 60, 1385–1389.CrossRefGoogle ScholarPubMed
Mitchell, T., Woodward, M. and Hirose, Y. (2008). A survey of attitudes of clinicians towards the diagnosis and treatment of mild cognitive impairment in Australia and New Zealand. International Psychogeriatrics, 20, 77–85.CrossRefGoogle ScholarPubMed
Nasreddine, Z. S.et al. (2005). The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatric Society, 53, 695–699.CrossRefGoogle Scholar
Petersen, R. C. and O'Brien, J. (2006). Mild cognitive impairment should be considered for DSM-V. Journal of Geriatric Psychiatry and Neurology, 19, 147–154.CrossRefGoogle ScholarPubMed
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G. and Kokmen, E. (1999). Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology, 56, 303–308.CrossRefGoogle ScholarPubMed
Petersen, R. C., Stevens, J. C., Ganguli, M., Tangalos, E. G., Cummings, J. L. and Dekosky, S. T. (2001a). Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 56, 1133–1142.CrossRefGoogle Scholar
Petersen, R. C.et al. (2001b). Current concepts in mild cognitive impairment. Archives of Neurology, 58, 1985–1992.CrossRefGoogle ScholarPubMed
Petersen, R. C.et al. (2006). Neuropathologic features of amnestic mild cognitive impairment. Archives of Neurology, 63, 665–672.CrossRefGoogle ScholarPubMed
Portet, F.et al. (2006). Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry, 77, 714–718.CrossRefGoogle Scholar
Rinne, J. O. and Nagren, K. (2010). Positron emission tomography in at risk patients and in the progression of mild cognitive impairment to Alzheimer's disease. Journal of Alzheimers Disease, 19, 291–300.CrossRefGoogle ScholarPubMed
Roberts, J. S., Karlawish, J. H., Uhlmann, W. R., Petersen, R. C. and Green, R. C. (2010). Mild cognitive impairment in clinical care: a survey of American Academy of Neurology members. Neurology, 75, 425–431.CrossRefGoogle Scholar
Sperling, R. A.et al. (2011). Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging–Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers and Dementia, 7, 280–292.CrossRefGoogle ScholarPubMed
Winblad, B.et al. (2004). Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine, 256, 240–246.CrossRefGoogle Scholar
Supplementary material: File

Rodda Supplementary Material

Appendix

Download Rodda Supplementary Material(File)
File 72.2 KB